Intelligence Platform
Patents
Browse 595 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 10258600
Aryl hydrocarbon receptor (AhR) modifiers as novel cancer therapeutics
granted patentUS 10231949
Inhibition of cancer cell motility
granted patentUS 10227352
Substituted 4-methyl-pyrrolo[1,2-A]pyrimidine-8-carboxamide compounds and uses thereof for
granted patentUS 10221164
Cannabinergic nitrate esters and related analogs
granted patentUS 10213397
Microtubule polymerization modulators for treating LMNA-related dilated cardiomyopathy
granted patentUS 10206875
Nanoemulsion compositions of taxoid drugs, and methods for the use thereof to target cance
granted patentUS 10201596
Peptide conjugated particles for the treatment of allergy
granted patentUS 10189807
Tetrahydrothiophene-based GABA aminotransferase inactivators
granted patentUS 10188711
Peptide conjugated particles
granted patentUS 10182988
Liposomal particles, methods of making same and uses thereof
granted patentUS 10179114
Phenolic coatings and methods of making and using same
granted patentUS 10167314
Methods of treating depression and other related diseases
granted patentUS 10167270
Substituted quinazoline compounds and uses thereof for modulating glucocerebrosidase activ
granted patentUS 10167263
Treatment of amyotrophic lateral sclerosis
granted patentUS 10118938
Arsenoplatin anti-cancer agents
granted patentUS 10111871
Nanoparticle drug delivery system and method of treating cancer and neurotrauma
granted patentUS 10105366
Selective calcium channel antagonists
granted patentUS 10098958
Delivery of oligonucleotide functionalized nanoparticles
granted patentUS 10098893
Methods of administering a trace amine-associated receptor 1 (TAAR1) agonist to patients h
granted patentUS 10093668
Substituted aromatic N-heterocyclic compounds as inhibitors of mitogen-activated protein k
granted patentUS 10040799
Substituted 4-methyl-pyrrolo[1,2-A]pyrimidine-8-carboxamide compounds and uses thereof for
granted patentUS 10016499
Multifunctional metal nanoparticles having a polydopamine-based surface and methods of mak
granted patentUS 9994817
Use of ligands for the programmed cell death receptor conjugated to solid supports for cul
granted patentUS 9993449
(S)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid, and related compounds
granted